Skip to main content
6125 search results for:

Rivaroxaban 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Rivaroxaban | News

    Rivaroxaban

    Lack of efficacy
  2. 01-05-2024 | Rivaroxaban | News

    Rivaroxaban

    Lack of efficacy
  3. 01-04-2024 | Rivaroxaban | News

    Rivaroxaban

    Exacerbation of bilateral adrenal haemorrhage resulting in adrenal insufficiency
  4. 01-04-2024 | Rivaroxaban | News

    Rivaroxaban

    Lack of efficacy
  5. 01-04-2024 | Rivaroxaban | News

    Rivaroxaban/warfarin

    Delayed intracranial haemorrhage
  6. 09-03-2024 | Rivaroxaban | ReviewPaper

    Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy

    The introduction of direct oral anticoagulants (DOACs) represents a major medical breakthrough, of which rivaroxaban is an example [ 1 ]. As the first oral direct inhibitor of factor Xa (FXa), rivaroxaban is approved for the treatment and …

  7. 01-03-2024 | Rivaroxaban | News

    Rivaroxaban

    Spontaneous chronic calf haematoma
  8. 01-03-2024 | Rivaroxaban | News

    Rivaroxaban

    Diffuse alveolar haemorrhage secondary to the acute mitral regurgitation
  9. 01-03-2024 | Rivaroxaban | News

    Rivaroxaban

    Pancreatitis
  10. 07-05-2024 | Rivaroxaban | Online First

    A systematic review and meta-analysis of the morbidity of efficacy endpoints and bleeding events in elderly and young patients treated with the same dose rivaroxaban

    Rivaroxaban is a new direct oral anticoagulant, and the same dose is recommended for older and young patients. However, recent real-world studies show that older patients may need dose adjustment to prevent major bleeding. At present, the evidence …

  11. Open Access 23-03-2024 | Levetiracetam | OriginalPaper

    The Effect of Levetiracetam Compared with Enzyme-Inducing Antiseizure Medications on Apixaban and Rivaroxaban Peak Plasma Concentrations

    The emergence of numerous antiseizure medications (ASMs) in the last 25 years has had a high impact on the management of epilepsy. Levetiracetam (LEV), introduced in 2000, offers distinct benefits that makes it a preferred choice over older ASMs.

  12. 01-02-2024 | Rivaroxaban | News

    Rivaroxaban

    Spinal epidural haematoma
  13. 01-02-2024 | Rivaroxaban | News

    Rivaroxaban

    Immediate hypersensitivity reactions
  14. Open Access 01-12-2024 | Rivaroxaban | OriginalPaper

    Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban

    Rivaroxaban (Xarelto®) is used to prevent stroke and systemic embolism in patients with atrial fibrillation (AF) and to treat venous thromboembolism (VTE). Two doses are available for treatment of atrial fibrillation, 20 mg Rivaroxaban once daily …

  15. 18-01-2024 | Rivaroxaban | OriginalPaper

    Therapy adherence, safety and efficacy of rivaroxaban in prevention of venous thromboembolism in patients with hip or knee endoprosthesis

    Venous thromboembolism including both deep vein thrombosis and pulmonary thromboembolism are frequent complications during and after surgery [ 1 ]. Orthopedic operations, especially total installation of hip or knee endoprosthesis, are very often …

  16. 01-01-2024 | Rivaroxaban | News

    Rivaroxaban

    Spontaneous haemothorax
  17. 21-12-2023 | Apixaban | OriginalPaper

    Efficacy and safety of rivaroxaban versus apixaban for venous thromboembolism: A systematic review and meta-analysis of observational studies

    Approximately 10 million cases of venous thromboembolism (VTE) are diagnosed each year worldwide [ 1 , 2 ] leading to significant morbidity and mortality [ 3 ]. Randomized controlled trials (RCTs) that compared DOACs to low molecular weight heparin …

  18. 01-12-2023 | Rivaroxaban | News

    Rivaroxaban

    DRESS syndrome
  19. Open Access 06-12-2023 | Rivaroxaban | Report

    Dual-Pathway Inhibition with Rivaroxaban and Low-Dose Aspirin Does Not Alter Immune Cell Responsiveness and Distribution in Patients with Coronary Artery Disease

    The leading cause of mortality globally is cardiovascular disease (CVD) [ 1 ]. Although there are many underlying causes for CVD, coronary artery disease (CAD) and peripheral artery disease (PAD) are primarily caused by atherosclerotic plaques …

  20. 01-12-2023 | Rivaroxaban | News

    Rivaroxaban

    Major bleed: case report

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.